Shahid Law Firm’s pharmaceuticals and healthcare practice is one of the cornerstones of our firm’s legal practice areas. The firm has earned its solid position in the market today through its comprehensive and multifaceted approach to advising companies in the industry.
The Firm’s strength lies in its understanding of client commercial needs which, coupled with knowledge of different legal systems in which we operate, longstanding experience in transactions and dispute resolution matters, as well as close ties to other leading firms in the region, ensures that the Firm’s aptitude in obtaining the best commercially oriented services for our clients.
The team combines Shahid Law Firm’s long-standing expertise in the evolving Egyptian legal and regulatory frameworks with an in-depth and practical understanding of concession agreements, corporate matters, an acute understanding of the dynamics of the pharmaceuticals and healthcare sectors, and a solid experience in dispute resolution in Egypt. Additionally, Shahid Law Firm represents international companies before various authorities handling the necessary regulatory procedures. We also provide advice to local producers on legal aspects of the manufacturing process relating to healthcare compliance practices, supply agreements, toll manufacturing, registration, and licensing, drafts and reviews agreements and memorandum of understanding.
Shahid Law Firm deals with all players in Egypt’s complex and multi-faceted pharmaceutical industry, including producers, distributors, agents and scientific offices. Our clients include some of the most prominent players in the industry, and span across pharmaceutical manufacturers, drug retailers, medical groups, professional associations, third-party administrators, and various healthcare authorities. Throughout its history, Shahid Law Firm’s Pharmaceutical and Healthcare team of attorneys have legally assisted clients in contentious and non-contentious matters, preserving their rights, acting for their favor, and helping them maintain their business.
Some of our services in the industry include:
- Advising a diverse range of clients in the pharmaceutical and healthcare sector, including governmental and public hospitals, private medical institutions, and military hospitals;
- Advising on regulatory and compliance matters and dealings with the Egyptian Drug Authority and the Unified Procurement Authority;
- Drafting and opining on agency and distribution, manufacturing under license and supply agreements on behalf of the principle;
- Advising on mergers and acquisitions (M&A), restructuring, due diligence, and other affiliation transactions;
- Advising on matters related to intellectual property, public policy and anti-competition practices;
- Assisting in obtaining the necessary licenses and permits, and IPR related registrations across a variety of jurisdictions;
- Handling litigation and arbitration cases;
- Handling corporate secretarial and labor matters; and
- Drafting and reviewing lease contracts for lands, administrative premises, and other property as well as assisting with registration procedures;
- Advising on other relevant areas of the law that are of particular interest to the healthcare and pharmaceutical sector.
- Advising major pharmaceutical companies on all their dealings with the Unified Procurement Authority, and all ongoing related matters associated with their agreement implementation.
- Representing an Indian multinational pharmaceutical company before the Egyptian Drug Authority (EDA), the General Organization for Export and Import Control, and Egyptian Ministry of Health (MOH) with regards to regulatory issues with the EDA as well as advising on the audit carried by the MOH to the factory located in India as well as advising on registration of pharmaceutical products and potential audit due diligence of its agent in Egypt.
- Representing Vitabiotics LLC in several misdemeanor cases pertaining to board members’ resolutions before the Egyptian Public Prosecutor’s Office and the Alexandria Economic Courts.
- Representing Vezeeta and Vezeeta E- Commerce in all of the criminal cases brought against their management personnel by the Egyptian Public Prosecution Office with respect to allegedly inter alia unlicensed practice of the pharmaceutical profession and unlawful marketing for medicinal products. Our involvement ensured that our client was found not in violation of any laws, marking a significant milestone in this transformative legal dispute.
- Representing a leading digital healthcare platform operating in the Middle East and Africa, has raised a USD 40 Million Series D funding round led by UAE-based Gulf Capital, alongside further investment from existing Riyadh-based investor.
- Representing GlaxoSmithKline (“GSK”) Group of Companies in many tax claims against the Minister of Finance with respect to wrong practices applied by the Ministry on the pharmaceutical industry. Our representation and defenses have established legal precedents that the Ministry now applies when dealing with the pharma sector post-judgment.
- Acting as a local counsel for GSK in the acquisition of the business of Bristol Myers Squibb in a USD 210 million deal; and in its acquisition of a local pharmaceutical company, Amoun Pharmaceutical Industries, at an approximate price of USD 105 million.
- Acting as local/legal counsel for GSK in its multi-billion dollars’ asset trading deal with Novartis, considered to have reshaped the pharmaceutical industry globally.
- Representing Pfizer in its attempted acquisition of a pharmaceutical company in Egypt in 2008.
- Acting as legal counsel for Abbott Laboratories Switzerland on providing the legal step plan regarding the actions that should be taken locally in Egypt jurisdiction, after implementing a conversion of Abbott Laboratories SA to a GmbH, so that the scientific office reflects the correct name of the entity that has registered said scientific office in Egypt.
- Acting as Legal Counsel for EVER Neuro Pharma and EVER Valinject GmbH with regards to reviewing distribution agreements and documentation related to handling the Scientific Office activity and advising on legal compliance aspects resulting from change in laws, specifically the Egyptian Drug Authority, all in relation to the jurisdiction of Egypt.
- Advising Bupa International on the application of Egyptian laws relating to marketing and sale of international private medical insurance over the Internet.
- Advising a British multinational consumer healthcare company on Egyptian bribery legislation and reporting requirements regarding certain conducts in its Egypt branch relating to its employees.
- Handling the day-to-day legal and secretarial work for Roche and Roche Diagnostics.
- Advising the winning consortium of the Alexandria University Hospitals PPP Project in relation to the tender requirements and shareholding structure of the project company.
- Acting as legal counsel in a multi-million USD capital increase/infusion of Eli Lilly Group of Companies, as well as on the restructuring of the board members and signatory powers of its legal entities in Egypt; and advised on civil and criminal liability of the board members
- Representing a Qatari private equity in its contemplated acquisition of an equity stake in Amoun Pharmaceutical Company, valued at USD 500 million.
- Advising Unicharm Corporation, a MENA-leading baby and health care products manufacturer, against Uni Sham for trademark violation with similar “Baby Boy” diapers. The Firm is worked with the Prosecution Office and Trademarks Registry to report the similarities, by representing Unicharm in a misdemeanor case, and managing the removal of the copied trademark to register the original one.
- Acting for different pharmaceutical companies and international manufacturers in various wrongful termination claim before Egyptian Labor Courts.
- Representing US and Irish leading pharmaceutical companies in dismissing claims of USD 5 Million, before Egyptian courts by an Egyptian distribution company.
- Representing a leading pharmaceutical company in white-collar related cases before Egyptian courts.
- Representing a rising company in the pharmaceutical field with respect to criminal investigations brought against it.
- Representing a leading pharmaceutical company and securing an arbitral award in its favor in a CRCICA arbitration claim worth EGP 92 million, related to a product-supply dispute with one of its distributors.
- Advising various Fortune 500 multinational pharmaceuticals company on all laws, decrees and regulations addressing and governing clinical trials in Egypt.
- Acting as counsel for various Fortune 500 multinational pharma by providing guidance on all regulatory and legal requirements as well as undertaking all the necessary work for their presence in Egypt.
- Advising Roche, Johnson & Johnson as well as various multinationals on clinical trials laws and regulations in Egypt as well as verified legal compliance of the agreements, assisting in multi-jurisdiction legal questionnaire related to clinical trials in Egypt jurisdiction, and providing legal framework on specific legal and regulatory requirements applicable on pharmaceutical companies.
- Advising the Association of Friends of the National Cancer Institute in relation to the tender requirements for the establishment of the Children’s Cancer Hospital Egypt (CCHE 57357).
- Acting on behalf of various pharmaceutical companies in restructuring their boards of directors and adjusting the signatory powers of their legal entities in Egypt. Additionally, we provide comprehensive advice on all disclosure requirements and procedures.
- Representing an international pharma giant in a claim to pay over EGP 50 million to a local distribution company on the background of an alleged breach of contract.
- Advising on the legal intricacies of donating a vast parcel of land located in Upper Egypt with a license to build a hospital on it.
- Advising a British multinational consumer healthcare company on Egyptian bribery legislation and reporting requirements regarding certain conducts in its Egypt branch relating to its employees.
- Advising various multinational companies on IPR, compulsory licensing, and exclusive marketing rights issues.
- Acting for various pharmaceutical and medical devices companies on all disputes arising from their relationships with their agents, distributors and manufacturers under license.
- Assisting two major pharmaceutical companies in lifting an attachment imposed on their accounts in multiple banks, based on a claimed real estate taxes dues amounting to millions of EGP.
